Music Listening to Lower Anxiety During ECT Treatment. (MIECT)

July 24, 2023 updated by: Lars Rye Bertelsen, Aalborg University

"Receptive Music Intervention for the Abatement of Anxiety for In-patients Diagnosed With Unipolar Depression Who Receive Standard ECT Treatment". (ECT: Electroconvulsive Therapy).

The purpose of this study is to assess whether music listening is helpful in lowering anxiety in patients about to start their ECT treatment.

Study Overview

Detailed Description

In-patients at a psychiatric hospital referred to ECT treatment, is offered to participate in the study investigating whether listening to expert-curated playlists before-, during and after ECT treatment is helpful as a non-pharmacological intervention in lowering patients anxiety.

After written informed consent, participants will be randomised into two groups, one listening to playlists with music, one listening to sounds from nature (e.g. rain, ocean waves). Playlists will be administered by tablet+earphones in the waiting room, tablet+speaker in the room of procedure and tablet+bedside speaker in the recovery room.

Study Type

Interventional

Enrollment (Estimated)

110

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Lars R Bertelsen, PhD. student
  • Phone Number: +4520406025
  • Email: Larb@hum.aau.dk

Study Locations

    • Region Nordjylland
      • Aalborg, Region Nordjylland, Denmark, 9000
        • Recruiting
        • Aalborg University Hospital, Psychiatry
        • Principal Investigator:
          • Lars R Bertelsen, PhD student
        • Contact:
          • Lars R Bertelsen, PhD Student
          • Phone Number: +4520406025
          • Email: larb@ikp.aau.dk

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Capable in-patients of age at Aalborg University Hospital, Psychiatry - departments S7

    • S8, diagnosed with unipolar depression, referred to ECT treatment.
  • patients assessed to fit the study, by the head of departments S7 & S8
  • Voluntary participation in the study after written informed consent.
  • Patients can withdraw their consent at any point during the treatment trajectory.

Exclusion Criteria:

  • Patients not compliant with the study, as assessed by head of departments
  • Non-capable patients
  • Patients who withdraw their written informed consent
  • Patients using hearing aid
  • Patients with former ECT treatment experience
  • Patients who receive acute ECT Treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Playlists with Expert-Curated Music - four weeks
Patients can choose from two expert-curated playlists with music, matching the trajectory of the ECT treatment (immediately before-, during and after the procedure). Playlists are available to the patients for four weeks (the first eight ECT procedures).
Patients choose between two expert-curated playlists with music one day prior to ECT procedures for the first four weeks of their ECT treatment.
Patients choose between two expert-curated playlists with music one day prior to ECT procedures for the first two weeks of their ECT treatment.
Active Comparator: Playlists with Expert-Curated Music - two weeks
Patients can choose from two expert-curated playlists with music, matching the trajectory of the ECT treatment (immediately before-, during and after the procedure). Playlists are available to the patients for two weeks (the first four ECT procedures).
Patients choose between two expert-curated playlists with music one day prior to ECT procedures for the first four weeks of their ECT treatment.
Patients choose between two expert-curated playlists with music one day prior to ECT procedures for the first two weeks of their ECT treatment.
Placebo Comparator: Playlists with Nature Sounds
Patients can choose from two expert-curated playlists with recorded sounds from nature (Rain, Waves) during ECT treatment (immediately before-, during and after the procedure). Playlists are available to the patients for four weeks (the first eight ECT procedures).
Patients choose between two expert-curated playlists with sounds from nature one day prior to ECT procedures for the first two weeks of their ECT treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
State-Trait Anxiety Inventory (STAI-Y1)
Time Frame: First week of ECT treatment

Measurement of patient anxiety before their first-, and before their second ECT procedure.

Patients report of anxiety before their ECT treatment and therefore their anxiety is measured in validated STAI-Y1 questionnaire the evening before the first and before the second ECT procedure.

First week of ECT treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
State-Trait Anxiety Inventory (STAI-Y1)
Time Frame: First four weeks of treatment.

Measurement of patient anxiety before their fifth.-, and before their ninth. ECT procedure.

Patients report of anxiety before their ECT treatment and therefore their anxiety is measured in validated STAI-Y1 questionnaire during their first 8 ECT treatments, to see differences in anxiety levels over time (if any).

First four weeks of treatment.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anxiety Symptom Scale questionnaire (ASS).
Time Frame: First four weeks of treatment.

Defining the type of anxiety.

Validated Anxiety Symptom Scale questionnaire (ASS), measured before 1st., 5th. and 9th. ECT procedure.

First four weeks of treatment.
Non/validated questionnaire on patients experience of treatment quality.
Time Frame: First four weeks of treatment.
Self-made questionnaire on patients' experience of the treatment quality using playlists as an add-on to Treatment As Usual (TAU).
First four weeks of treatment.
Semi-structured Follow-Up interview.
Time Frame: One month after last ECT treatment
Qualitative Follow-Up interview with two participants from each arm, approximately four weeks after their last ECT procedure.
One month after last ECT treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lars R Bertelsen, Aalborg University, Doctoral Programme of Music Therapy.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2021

Primary Completion (Estimated)

August 1, 2024

Study Completion (Estimated)

December 1, 2024

Study Registration Dates

First Submitted

January 11, 2021

First Submitted That Met QC Criteria

January 11, 2021

First Posted (Actual)

January 13, 2021

Study Record Updates

Last Update Posted (Actual)

July 25, 2023

Last Update Submitted That Met QC Criteria

July 24, 2023

Last Verified

August 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • VEK N-20200038

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Collected data is solely used for publishing PhD. articles.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anxiety State

Clinical Trials on Listening to playlists with music prior to-, during and after the ECT procedure

3
Subscribe